The peculiarities of etiological verification of pulmonary TB in patients with chronic renal disease in the terminal stage before and after kidney transplantation

O. Gordeeva (Moscow, Russian Federation)

Source: International Congress 2017 – TB: co-morbidities and outcome
Session: TB: co-morbidities and outcome
Session type: Thematic Poster
Number: 2721
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Gordeeva (Moscow, Russian Federation). The peculiarities of etiological verification of pulmonary TB in patients with chronic renal disease in the terminal stage before and after kidney transplantation. 2721

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The value of immunological methods in the complex diagnostics of TB in chronic renal failure patients in the terminal stage
Source: International Congress 2019 – Tuberculosis: diagnosis
Year: 2019

Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007

The role of bronchoscopy in the differential diagnosis of pulmonary lesions in end-stage renal disease patients
Source: Virtual Congress 2020 – Conventional bronchoscopy
Year: 2020


Prevalence, correlates and mortality impact of chronic obstructive pulmonary disease in end stage kidney disease
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Prognostic factors in patients with end stage idiopathic pulmonary fibrosis awaiting lung transplantation
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009


Frequency and features of formation of chronic kidney disease (CKD) in patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019

Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019


Pulmonary function in patients with end-stage renal disease and renal transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 56s
Year: 2004

The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Pulmonary hypertension in end-stage renal disease and post renal transplantation patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013


Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation?
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012


The difficulties of functional class heart failure assessment in the patients with concomitant chronic obstructive pulmonary disease
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Tuberculosis in patients with chronic renal failure
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010


Analysis of parameters of lung function in patients with severe chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 214s
Year: 2001

Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015

Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009


Pulmonary veno-occlusive disease is highly prevalent in scleroderma patients undergoing lung transplantation
Source: ERJ Open Res, 5 (1) 00168-2018; 10.1183/23120541.00168-2018
Year: 2019



Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation
Source: Eur Respir J 2012; 39: 1520-1533
Year: 2012